PURPOSE: To analyze a multidisciplinary community experience with oncoplastic breast surgery (OBS) and postoperative radiation therapy (RT). METHODS: The records of 79 patients with localized breast cancer who underwent OBS+RT were reviewed. OBS included immediate reconstruction and contralateral mammoreduction. All patients had negative surgical margins. Whole-breast RT was delivered without boost. A subset of 44 patients agreed to complete a validated quality of life survey pre-RT, post-RT, 6 months after RT, and at final follow-up assessing cosmesis and treatment satisfaction. RESULTS: Sixty-seven patients (85%) were white. Median age was 62 years. Median interval between OBS and RT start was 9.6 weeks. Median RT dose was 46 Gy. Fourteen patients (18%) developed surgical toxicities before RT. Five patients (6%) developed RT toxicities. Physician rating of cosmesis post-RT was: 3% excellent, 94% good, and 4% fair. Cosmesis was rated as excellent or good by 87% of patients pre-RT, 82% post-RT, 75% at 6 months, and 88% at the final follow-up. Treatment satisfaction was rated as "total" or "somewhat" by 97% of patients pre-RT, 93% post-RT, 75% at 6 months, and 96% at final follow-up. No significant relation was found between patient or treatment-related factors and toxicity. Local control is 100% at median follow-up of 2.9 years. CONCLUSIONS: OBS followed by RT resulted in acceptable toxicity and favorable physician-rated cosmesis in this large community series. Patients' ratings of cosmesis and treatment satisfaction were initially high, decreasing at 6 months, returning near baseline at final follow-up.
PURPOSE: To analyze a multidisciplinary community experience with oncoplastic breast surgery (OBS) and postoperative radiation therapy (RT). METHODS: The records of 79 patients with localized breast cancer who underwent OBS+RT were reviewed. OBS included immediate reconstruction and contralateral mammoreduction. All patients had negative surgical margins. Whole-breast RT was delivered without boost. A subset of 44 patients agreed to complete a validated quality of life survey pre-RT, post-RT, 6 months after RT, and at final follow-up assessing cosmesis and treatment satisfaction. RESULTS: Sixty-seven patients (85%) were white. Median age was 62 years. Median interval between OBS and RT start was 9.6 weeks. Median RT dose was 46 Gy. Fourteen patients (18%) developed surgical toxicities before RT. Five patients (6%) developed RT toxicities. Physician rating of cosmesis post-RT was: 3% excellent, 94% good, and 4% fair. Cosmesis was rated as excellent or good by 87% of patients pre-RT, 82% post-RT, 75% at 6 months, and 88% at the final follow-up. Treatment satisfaction was rated as "total" or "somewhat" by 97% of patients pre-RT, 93% post-RT, 75% at 6 months, and 96% at final follow-up. No significant relation was found between patient or treatment-related factors and toxicity. Local control is 100% at median follow-up of 2.9 years. CONCLUSIONS: OBS followed by RT resulted in acceptable toxicity and favorable physician-rated cosmesis in this large community series. Patients' ratings of cosmesis and treatment satisfaction were initially high, decreasing at 6 months, returning near baseline at final follow-up.
Authors: Florian Fitzal; Martina Mittlboeck; Herwig Trischler; Wilfried Krois; Greta Nehrer; Maria Deutinger; Raimund Jakesz; Michael Gnant Journal: Ann Surg Date: 2008-03 Impact factor: 12.969
Authors: M Rietjens; C A Urban; P C Rey; G Mazzarol; P Maisonneuve; C Garusi; M Intra; S Yamaguchi; N Kaur; F De Lorenzi; A G Z Matthes; S Zurrida; J Y Petit Journal: Breast Date: 2007-03-26 Impact factor: 4.380
Authors: Thomas E Goffman; Heather Schneider; Karen Hay; David E Elkins; Robert A Schnarrs; Claire Carman Journal: Breast J Date: 2005 May-Jun Impact factor: 2.431
Authors: M L Smith; G R Evans; A Gürlek; M Bouvet; S E Singletary; F C Ames; N Janjan; M D McNeese Journal: Ann Plast Surg Date: 1998-09 Impact factor: 1.539
Authors: S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold Journal: Lancet Date: 2008-03-19 Impact factor: 79.321
Authors: Jennifer J Yoon; William Ross Green; Sinae Kim; Thomas Kearney; Bruce G Haffty; Firas Eladoumikdachi; Sharad Goyal Journal: Adv Radiat Oncol Date: 2016-09-21
Authors: Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff Journal: BJS Open Date: 2021-11-09
Authors: Ahmad Kaviani; Nassim Sodagari; Sara Sheikhbahaei; Vahid Eslami; Nima Hafezi-Nejad; Amin Safavi; Maryam Noparast; Alfred Fitoussi Journal: ISRN Oncol Date: 2013-09-12